Official ESCRS | European Society of Cataract & Refractive Surgeons
Barcelona 2015 Programme Registration Glaucoma Day 2015 Exhibition Virtual Exhibition Satellite Meetings Hotel Booking Star Alliance
ISTANBUL escrs









Take a look inside the London 2014 Congress

video-icon

Then register to join us
in Barcelona!





XFS/ XFG and cataract extraction

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Session Details

Session Title: Presented Poster Session: Cataract Surgery Complications and Management II

Session Date/Time: Saturday 05/09/2015 | 15:00-16:30

Paper Time: 15:40

Venue: Poster Village: Pod 1

First Author: : Y.Kirilova BULGARIA

Co Author(s): :    P. Vassileva              

Abstract Details

Purpose:

To observed patients with XFS / XFG, operated for cataract and to analyzed surgical technique and complications rate.

Setting:

Prospective study of all patients underwent for cataract surgery (10.2014- 12. 2014) and followed up 3 to 5 months.

Methods:

Full eye examination was done in all patients, and in some of them VF, OCT, CCT, gonioscopy and endothelial microscopy. Surgical methods include: phacoemulsification of the cataract and extracapsular cataract extraction with IOL implantation .

Results:

196 patients were operated, 39 (20%) with XFS and 12 of them (6%) with XFG. According to the surgery: 165 patients (84%) with phaco and 31 patients (16%) with ECCE. We observed rupture of the posterior capsule in 5 patients (2.5%), in two patients (0.5%) IOL was fixed for the iris, in two (1%) - we used iris – retractors and one patient (0.5%) with AC-IOL. In the majority of patients we registered a decrease in IOP after surgery with 1-2 mmHg, in 6 patients (3%) high IOP was measured postop- 27mmHg (23-45mmHg) and one (0.5%) had filtering surgery after phaco. Transition corneal edema was observed in 37 patients (19%), with exfoliations were 22 of them (11%).

Conclusions:

Timely cataract extraction in patients with XFS / XFG can normalize IOP in most cases and reduce risk of complications.

Financial Interest:

NONE

Back to previous